Benign Prostatic Hyperplasia Clinical Trials, Treatment Drugs, Emerging Therapies and Companies 2024

DelveInsight's, "Benign Prostatic Hyperplasia Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Benign Prostatic Hyperplasia pipeline landscape. It covers the Benign Prostatic Hyperplasia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Benign Prostatic Hyperplasia Pipeline. Dive into DelveInsight's comprehensive report today! @ Benign Prostatic Hyperplasia Pipeline Outlook-= https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Benign Prostatic Hyperplasia Pipeline Report
• July 2024:- EMS- Phase III, Multicenter, Randomized, Double-blind Clinical Trial to Assess the Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia. The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia
• July 2024:- Vedic Lifesciences Pvt. Ltd.- The present study is a randomized, double-blind, placebo-controlled study. Approximately 125 individuals will be screened, and considering a screening failure rate of 20%, at least 100 will be randomized in a ratio of 1:1 to receive either IP or placebo and will be assigned a unique randomization code. Each group will have not less than 40 completed participants after accounting for a dropout/withdrawal rate of 20%. The intervention duration for all the study participants is 90 days.
• DelveInsight's Benign Prostatic Hyperplasia pipeline report depicts a robust space with 10+ active players working to develop 10+ pipeline therapies for Benign Prostatic Hyperplasia treatment.
• The leading Benign Prostatic Hyperplasia Companies such as GemVax & Kael, Antev, Dongkook Pharmaceutical, Chong Kun Dang Pharmaceutical, Resurge Therapeutics Inc., DMK Pharmaceuticals, and others
• Promising Benign Prostatic Hyperplasia Therapies such as CKD-846, D091, Paclitaxel, alpha blocker and 5-alpha reductase inhibitor, DTT106, Dutasteride-Tamsulosin, and others.

Stay ahead with the most recent pipeline outlook for Benign Prostatic Hyperplasia. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Benign Prostatic Hyperplasia Treatment Drugs- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Benign Prostatic Hyperplasia Emerging Drugs Profile

• DKF-313: Dongkook Pharmaceutical
DKF-313, a combination of dutasteride and tadalafil, is expected to reduce prostate size and improve dysuria symptoms caused by BPH more effectively than single drugs. This combination targets specific antigens overexpressed on cancer cells, allowing for selective targeting. By binding to these target antigens, DKF-313 can deliver the drugs directly to the affected cells, enhancing treatment outcomes. Currently, the drug is in Phase III stage of its clinical trial for the treatment of benign prostatic hyperplasia.

• Teverelix trifluoroacetate: Antev
Teverelix trifluoroacetate (Teverelix TFA) is a gonadotrophin-releasing hormone (GnRH) antagonist with a novel formulation. GnRH antagonists rapidly suppress the effects of sex hormones by limiting their production. This is therapeutically valuable for conditions that are controlled by sex hormone secretion, including prostate cancer, benign prostatic hyperplasia, and endometriosis. Recent data suggest that GnRH antagonists may have multiple therapeutic advantages over the traditionally used GnRH agonists, and therefore have the potential to supersede GnRH agonists as the gold-standard treatment. Currently, the drug is in Phase II stage of its clinical trial for the treatment of benign prostatic hyperplasia.

• DPI-221: DMK Pharmaceuticals
DPI-221 by DMK Pharmaceuticals is a drug that acts as a highly selective agonist for the δ-opioid receptor, known for producing fewer convulsions compared to other drugs in the same family. This drug is a novel nonpeptide delta receptor agonist that has shown effects such as increased micturition interval in normal rats. Currently, the drug is in Phase I stage of its clinical trial for the treatment of benign prostatic hyperplasia.

Explore groundbreaking therapies and clinical trials in the Benign Prostatic Hyperplasia Pipeline. Access DelveInsight's detailed report now! @ New Benign Prostatic Hyperplasia Drugs- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Benign Prostatic Hyperplasia (BPH) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Benign Prostatic Hyperplasia Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Unveil the future of Benign Prostatic Hyperplasia Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Benign Prostatic Hyperplasia Market Drivers and Barriers- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Benign Prostatic Hyperplasia Pipeline Report
• Coverage- Global
• Benign Prostatic Hyperplasia Companies- GemVax & Kael, Antev, Dongkook Pharmaceutical, ChongKun Dang Pharmaceutical, Resurge Therapeutics Inc., DMK Pharmaceuticals, and others
• Benign Prostatic Hyperplasia Therapies- CKD-846, D091, Paclitaxel, alpha blocker and 5-alpha reductase inhibitor, DTT106, Dutasteride-Tamsulosin, and others.
• Benign Prostatic Hyperplasia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Benign Prostatic Hyperplasia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Benign Prostatic Hyperplasia Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Benign Prostatic Hyperplasia Companies, Key Products and Unmet Needs-- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Benign prostatic hyperplasia: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Benign prostatic hyperplasia- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. DKF-313: Dongkook Pharmaceutical
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Teverelix trifluoroacetate: Antev
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. DPI-221: DMK Pharmaceuticals
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Benign prostatic hyperplasia Key Companies
21. Benign prostatic hyperplasia Key Products
22. Benign prostatic hyperplasia- Unmet Needs
23. Benign prostatic hyperplasia- Market Drivers and Barriers
24. Benign prostatic hyperplasia- Future Perspectives and Conclusion
25. Benign prostatic hyperplasia Analyst Views
26. Benign prostatic hyperplasia Key Companies
27. Appendix

List of Top Selling Market Research Reports in 2024

Abdominal Aortic Aneurysm Market- https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market
Acute Myeloid Leukemia Market- https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market
Adult T-cell Leukemia Market- https://www.delveinsight.com/report-store/adult-t-cell-leukemia-lymphoma-market
Alcoholic Hepatitis Market- https://www.delveinsight.com/report-store/alcoholic-hepatitis-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Blastomycosis Market- https://www.delveinsight.com/report-store/blastomycosis-market
Carbapenem-resistant Enterobacteriaceae Infection Market- https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Central Retinal Vein Occlusion Market- https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market
Clostridium Difficile Infections Market- https://www.delveinsight.com/report-store/clostridium-difficile-infections-clostridium-difficile-associated-disease-market
Congenital Heart Defect Market- https://www.delveinsight.com/report-store/congenital-heart-defect-devices-market
Diabetic Gastroparesis Market- https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
Familial Adenomatous Polyposis Market- https://www.delveinsight.com/report-store/familial-adenomatous-polyposis-market
Gastroparesis Market- https://www.delveinsight.com/report-store/gastroparesis-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Trauma Fixation Devices Market- https://www.delveinsight.com/report-store/trauma-devices-market
Vascular Imaging Devices Market- https://www.delveinsight.com/report-store/vascular-imaging-market-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Pacemakers Market- https://www.delveinsight.com/report-store/pacemakers-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Intraocular Lymphoma Market- https://www.delveinsight.com/report-store/intraocular-lymphoma-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Transcatheter Heart Valve Replacement Devices Market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
Endoscopic Ultrasound Market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Trichomoniasis Market- https://www.delveinsight.com/report-store/trichomoniasis-market-insights
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
CXCR Inhibitors Market- https://www.delveinsight.com/report-store/c-x-c-chemokine-receptor-inhibitors-competitive-landscape-market-and-pipeline-analysis
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Pigment Epithelial Detachment Market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
+91-9650213330

This release was published on openPR.